Job F H Eijsink

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Multiple Myeloma

Gestational Age

Candida Albicans

Top Venues

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Job F H Eijsink, André Wieringa, Marie-Therese L M Vries-Koenjer, Peter G J Ter Horst
Anidulafungin Levels in Breast Milk After Cessation of Treatment: A Case Report. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine 19 (2) (2024)
Job F H Eijsink, André Wieringa, Marie-Therese L M Vries-Koenjer, Peter G J Ter Horst
Anidulafungin Levels in Breast Milk After Cessation of Treatment: A Case Report. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine 19 (2) (2024)
Job F H Eijsink, Paul A F Geerts, Karin Kamminga, Mireille A Edens, Cornelis Boersma, Maarten J Postma, Jan Gerard Maring, Peter G J Ter Horst
The impact of telemonitoring on correct drug use, complications and quality of life among patients with multiple myeloma (ITUMM): A study protocol for an open-label, parallel-group, randomized controlled trial. PloS one 19 (8) (2024)
Job F H Eijsink, André Wieringa, Marie-Therese L M Vries-Koenjer, Peter G J Ter Horst
Anidulafungin Levels in Breast Milk After Cessation of Treatment: A Case Report. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine 19 (2) (2024)
Job F H Eijsink, André Wieringa, Marie-Therese L M Vries-Koenjer, Peter G J Ter Horst
Anidulafungin Levels in Breast Milk After Cessation of Treatment: A Case Report. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine (2024)
Job F H Eijsink, Paul A F Geerts, Karin Kamminga, Mireille A Edens, Cornelis Boersma, Maarten J Postma, Jan Gerard Maring, Peter G J Ter Horst
The impact of telemonitoring on correct drug use, complications and quality of life among patients with multiple myeloma (ITUMM): A study protocol for an open-label, parallel-group, randomized controlled trial. PloS one 19 (8) (2024)